Tolerance and Effect on Intraocular Pressure After Administration of SYL040012

Clinical trial NCT00990743 · COMPLETED

Trial details

NCT number: NCT00990743
Sponsor: Sylentis, S.A.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Ocular Hypertension Glaucoma

Start date: 2009-09-01
Primary completion: 2010-06-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.